Lower diligence level linked to higher cardiovascular disease risk in type 2 diabetes

But adopting healthy lifestyle still beneficial, irrespective of this trait, findings show People with type 2 diabetes, who display lower levels of diligence, may have a significantly higher risk of developing cardiovascular disease with which diabetes is strongly associated, finds research published in the open access journal BMJ Open Diabetes Research ...

2024-09-11T09:57:22+01:0011 September 2024|BMJ Open Diabetes Research and Care, Press release|

Prostate cancer rates across Europe since 1980 “indicative of overdiagnosis” say experts

Findings reinforce need for carefully planned screening programmes to minimise harms of overdiagnosis Rates of prostate cancer across Europe since 1980 are “indicative of overdiagnosis”, say researchers in a study published by The BMJ today. Overdiagnosis refers to the detection of harmless cancers that are unlikely to cause symptoms or death during ...

2024-09-05T09:09:56+01:005 September 2024|Press release, The BMJ|

Certain diabetes drugs might prevent dementia

But randomised controlled trials are needed to confirm these findings Sodium-glucose cotransporter-2 (SGLT-2) inhibitors used to treat type 2 diabetes might prevent dementia, providing greater benefits with longer treatment, suggests a large study from Korea published by The BMJ today. As this study was observational, the researchers note that the effect size ...

2024-08-29T07:46:52+01:0029 August 2024|Press release, The BMJ|

New study provides further support for psilocybin’s potential to treat depressive symptoms

High dose psilocybin was the only psychedelic treatment to reduce depressive symptoms by more than placebo in antidepressant trials High doses of psilocybin - the active ingredient in magic mushrooms - appears to have a similar effect on depressive symptoms as the selective serotonin reuptake inhibitor (SSRI) drug escitalopram, suggests ...

2024-08-22T10:48:26+01:0022 August 2024|Press release, The BMJ|
Go to Top